NasdaqGS:GRALBiotechs
GRAIL (GRAL) Q1 2026 Heavy US$93 Million Loss Tests High 16.5x Sales Multiple
GRAIL (NasdaqGS:GRAL) Q1 2026 Results in Focus
GRAIL (NasdaqGS:GRAL) opened 2026 with Q1 revenue of US$40.8 million, a basic EPS loss of US$2.29 and net income loss of US$93.2 million, setting a cautious tone against a share price of US$62.75. Over recent quarters the company has seen revenue move from US$31.8 million in Q1 2025 to US$40.8 million in Q1 2026. Quarterly basic EPS losses have ranged between US$2.29 and US$3.18, keeping the spotlight firmly on how quickly the business model can...